|
Glenmark Pharmaceuticals Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
52472.42 Cr.
|
P/BV
|
6.21
|
Book Value (Rs.)
|
299.28
|
|
52 Week High/Low (Rs.)
|
1843/1272
|
FV/ML
|
1/1
|
P/E(X)
|
50.11
|
|
Bookclosure
|
27/09/2024
|
EPS (Rs.)
|
37.10
|
Div Yield (%)
|
0.13
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 6522.04 | 6623.80 | 5569.65 | 6243.44 | 6764.47 |
| Other Operating Income | 121.72 | 54.18 | 0.00 | 0.00 | 73.10 |
| Total Income From Operations | 6643.76 | 6677.98 | 5569.65 | 6243.44 | 6837.57 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 1541.14 | 1460.13 | 1411.81 | 1746.01 | 1750.98 |
| Purchase of Traded Goods | 762.90 | 803.11 | 623.91 | 827.26 | 684.70 |
| Increase/Decrease in Stocks | -130.85 | -83.08 | -7.94 | -187.69 | -77.50 |
| Employees Cost | 1525.06 | 1497.01 | 1453.99 | 1414.15 | 1413.58 |
| Depreciation | 247.94 | 238.07 | 298.41 | 283.49 | 308.81 |
| Other Expenses | 1784.26 | 1810.69 | 1792.18 | 1544.07 | 1840.61 |
| Total Expenses | 5730.45 | 5725.92 | 5572.37 | 5627.30 | 5921.17 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 913.31 | 952.06 | -2.72 | 616.14 | 916.40 |
| Other Income | 42.81 | 70.91 | 818.58 | 21.42 | 36.20 |
| P/L Before Interest, Excpt. Items & Tax | 956.12 | 1022.97 | 815.86 | 637.56 | 952.60 |
| Interest | 119.01 | 88.06 | 282.90 | 233.07 | 206.52 |
| P/L Before Exceptional Items & Tax | 837.12 | 934.91 | 532.95 | 404.50 | 746.08 |
| Exceptional Items | -372.82 | 0.00 | -523.51 | -377.45 | -765.85 |
| P/L Before Tax | 464.30 | 934.91 | 9.45 | 27.05 | -19.77 |
| Tax | 111.89 | 240.18 | 1697.67 | 169.67 | 92.60 |
| P/L After Tax from Ordinary Activities | 352.42 | 694.72 | -1688.23 | -142.62 | -112.38 |
| Extra Ordinary Item | 0.00 | 0.00 | 143.14 | 254.19 | 0.00 |
| Net Profit/Loss For the Period | 352.42 | 694.72 | -1545.09 | 111.57 | -112.38 |
| Minority Interest | 0.20 | -0.24 | -24.57 | -43.58 | -25.17 |
| Net P/L After Minority Interest & Share Of Associates | 352.61 | 694.48 | -1569.66 | 67.99 | -428.30 |
| | | | | | |
| Equity Share Capital | 28.22 | 28.22 | 28.22 | 28.22 | 28.22 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 12.49 | 24.61 | -54.75 | 2.41 | -3.98 |
| Diluted EPS (Rs.) | 124.88 | 24.61 | (598.24) | 2.41 | (39.82) |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 12.49 | 24.61 | -54.75 | 2.41 | -3.98 |
| Diluted EPS (Rs.) | 0.00 | 24.61 | 0.00 | 2.41 | 0.00 |
| | | | | | |
| PBITOE Margin (%) | 13.74 | 14.25 | -0.04 | 9.86 | 13.40 |
| PBTE Margin (%) | 12.60 | 13.99 | 9.56 | 6.47 | 10.91 |
| PBT Margin (%) | 6.98 | 13.99 | 0.16 | 0.43 | -0.28 |
| PAT Margin (%) | 5.30 | 10.40 | -27.74 | 1.78 | -1.64 |
| PAT After MI And SOA Margin (%) | 5.30 | 10.39 | -28.18 | 1.08 | -6.26 |
